Smead Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$139M |
| 2 |
American Express
AXP
|
+$17.3M |
| 3 |
Amgen
AMGN
|
+$15.1M |
| 4 |
Target
TGT
|
+$14.6M |
| 5 |
Merck
MRK
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$143M |
| 2 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$8.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.53% |
| 2 | Financials | 16.28% |
| 3 | Energy | 15.87% |
| 4 | Healthcare | 15.48% |
| 5 | Real Estate | 7.63% |
Similar funds
Smead Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Smead Capital Management held 32 positions worth $3.91B, down 9.3% from $4.31B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Smead Capital Management deployed $206M of net new capital in Q2 2022, opening 1 new position and adding to 28 existing holdings. Its largest new stake was Frontline: 296,905 shares worth $2.66M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was CONTINENTAL RESOURCES INC., an estimated $8.32M trimmed.
- Smead Capital Management's largest Q2 2022 buy was Frontline: 296,905 shares worth $2.66M.
- Smead Capital Management added most to Warner Bros in Q2 2022, an estimated $139M increase.
- Smead Capital Management's biggest Q2 2022 reduction was CONTINENTAL RESOURCES INC., cutting an estimated $8.32M.
- Smead Capital Management fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $143M.
- Smead Capital Management's ten largest holdings make up 61% of its $3.91B portfolio in Q2 2022.
- Smead Capital Management opened 1 new position and closed 1 in Q2 2022.
- Smead Capital Management's portfolio value fell 9.3% quarter-over-quarter to $3.91B.
Based on Smead Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.